Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial.

Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial. Eur J Heart Fail. 2022 06; 24(6):996-1005.

View in: PubMed

subject areas

Diabetes Mellitus, Type 2
Diabetic Nephropathies
Double-Blind Method
Heart Failure
Humans
Mineralocorticoid Receptor Antagonists
Naphthyridines
Renal Insufficiency, Chronic

authors with profiles

George Bakris